Table 1 Demography and clinical characteristics among the studied groups
From: 4C mortality score and CT severity score among COVID-19 patients: a single center prospective study
Variable | Group I | Group II | Group III | p value | ||
|---|---|---|---|---|---|---|
(n = 78) | (n = 97) | (n = 121) | ||||
Moderate | Severe | Critical | I versus II | I versus III | II versus III | |
Age (years) | 48.3 ± 15.4 | 57.6 ± 12.5 | 64.5 ± 10.8 | 0.0001a | ||
0.0001 | 0.0001 | 0.0001 | ||||
Gender, n (%) | ||||||
Males | 59 (75.7%) | 58 (59.8%) | 70 (57.8%) | 0.023b | ||
Females | 19 (24.3%) | 39 (40.2%) | 51 (42.1%) | 0.028 | 0.008 | 0.692 |
Smoking, n (%) | ||||||
Current | 15 (19.2%) | 22 (22.7%) | 30 (24.8%) | 0.34b | ||
Ex-smoker | 8 (10.3%) | 18 (18.5%) | 22 (18.2%) | |||
Non-smoker | 55 (70.5%) | 57 (58.8%) | 69 (57%) | |||
Fever, n (%) | 75 (96.1%) | 94 (96.9%) | 117(96.7%) | 0.689b | ||
Dyspnea, n (%) | 55 (69.5%) | 97 (100%) | 121 (100%) | 0.0001b | ||
0.0001 | 0.0001 | 0.99 | ||||
Dry cough, n (%) | 68 (87.2%) | 90 (92.8%) | 115(95.1%) | 0.091b | ||
Diarrhea, n (%) | 36 (37.2%) | 43 (44.3%) | 40 (33.1%) | 0.159b | ||
Vomiting, n (%) | 14 (17.9%) | 23 (23.7%) | 14 (11.6%) | 0.025b | ||
0.435 | 0.084 | 0.007 | ||||
Loss of taste and smell, n (%) | 35 (44.9%) | 20 (20.6%) | 2 (1.7%) | 0.0001b | ||
0.001 | 0.0001 | 0.0001 | ||||
Respiratory rate (mean ± SD) | 23.7 ± 4.3 | 29.2 ± 6.2 | 35.8 ± 7.1 | 0.0001a | ||
0.0001 | 0.0001 | 0.0001 | ||||
SpO2% (mean ± SD) | 95.3 ± 1.7 | 83.9 ± 6.9 | 64.1 ± 14.8 | 0.0001a | ||
0.0001 | 0.0001 | 0.0001 | ||||